drugset / Trial / NCT00262249

Effect of Growth Hormone in Children With Growth Hormone Deficiency

NCT00262249

Phase 3 Completed 173 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in the United States of America (USA). The purpose of the trial is to compare the effect of Norditropin® using different dosing regimens in children suspected of growth hormone deficiency.

Timeline

Start
2000-08
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 40 ug/kg